WHO ICTRP trial
The application of remidazolam combined with esketamine in hysteroscopic…
ChiCTR2000041088 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000041088 |
|---|---|
| Public title | The application of remidazolam combined with esketamine in hysteroscopic surgery: a randomized controlled trial. |
| Scientific title | The application of remidazolam combined with esketamine in hysteroscopic surgery |
| Primary sponsor | Liuzhou Workers Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | endometrial polyp |
| Interventions | remidazolam and esketamine group:remidazolam and esketamine;esketamine and propofol group:esketamine and propofol;sufentannil and propofol group:sufentannil and propofol |
| Registration date | Dec 17, 2020 |
| Target size | remidazolam and esketamine group:30;esketamine and propofol group:30;sufentannil… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: